Loading…
India Pesticides (IPL)₹116.78−0.49%Pesticides & Agrochemicals
In the Jun 2026 quarter (consolidated), India Pesticides reported sales of ₹253 Cr, down 8.4% from Jun 2025, and net profit of ₹23.06 Cr, down 34.2% year on year. For the year to Mar 2026, sales were ₹1,060 Cr and net profit ₹120 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 203 | 151 | 126 | 221 | 230 | 173 | 208 | 276 | 291 | 225 | 267 | 253 |
| Expenses | 176 | 118 | 122 | 193 | 196 | 147 | 177 | 231 | 243 | 189 | 226 | 217 |
| Operating Profit | 27.07 | 33.07 | 4.01 | 28.05 | 34.08 | 27.04 | 32.07 | 45.07 | 49.11 | 38.06 | 42.08 | 35.05 |
| OPM % | 13.0% | 22.0% | 3.0% | 13.0% | 15.0% | 15.0% | 15.0% | 16.0% | 17.0% | 17.0% | 16.0% | 14.0% |
| Other Income | 3.99 | 3.99 | 3.99 | 3.99 | 4.99 | 2.99 | 2.99 | 8.98 | 4.99 | 2.99 | 3.99 | 3.99 |
| Interest | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 1.99 | 0.99 | 0.99 | 2.99 | 2.99 |
| Depreciation | 4.01 | 4.01 | 4.01 | 4.01 | 4.01 | 5.01 | 5.01 | 5.01 | 5.01 | 6.01 | 5.01 | 6.01 |
| Profit before tax | 27.07 | 32.11 | 2.01 | 27.08 | 34.08 | 23.07 | 29.08 | 47.10 | 47.12 | 34.07 | 38.09 | 31.09 |
| Tax % | 26.1% | 26.1% | 47.1% | 27.0% | 23.1% | 31.1% | 25.1% | 26.1% | 33.1% | 33.1% | 19.1% | 26.1% |
| Net Profit | 20.05 | 24.07 | 1.01 | 19.05 | 26.06 | 16.03 | 22.05 | 35.06 | 32.07 | 23.06 | 31.04 | 23.06 |
| EPS (Rs) | 1.70 | 2.09 | 0.10 | 1.70 | 2.26 | 1.41 | 1.90 | 3.04 | 2.75 | 1.98 | 2.67 | 1.98 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|
| Sales | 651 | 718 | 887 | 681 | 831 | 1,060 | 1,036 |
| Expenses | 467 | 504 | 691 | 596 | 712 | 888 | 874 |
| Operating Profit | 183 | 214 | 198 | 87.18 | 120 | 174 | 164 |
| OPM % | 28.0% | 30.0% | 22.0% | 13.0% | 14.0% | 16.0% | 15.9% |
| Other Income | 5.98 | 12.97 | 12.96 | 14.96 | 14.97 | 20.95 | 15.96 |
| Interest | 2.99 | 6.98 | 6.98 | 3.99 | 4.98 | 6.97 | 7.96 |
| Depreciation | 6.01 | 9.02 | 11.02 | 15.02 | 18.02 | 21.02 | 22.04 |
| Profit before tax | 181 | 213 | 193 | 82.28 | 111 | 166 | 150 |
| Tax % | 25.1% | 25.0% | 25.1% | 27.1% | 26.1% | 28.1% | — |
| Exceptional items | 0.00 | 1.01 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | 135 | 158 | 143 | 60.15 | 82.19 | 120 | 109 |
| EPS (Rs) | 12.07 | 13.77 | 12.48 | 5.24 | 7.17 | 10.44 | 9.38 |
| Dividend payout % | 3.0% | 5.0% | 6.0% | 14.0% | 11.0% | 7.0% | — |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 10.96 | 11.96 | 11.96 | 11.96 | 11.96 | 11.95 |
| Reserves | 378 | 626 | 761 | 813 | 886 | 997 |
| Borrowings | 29.97 | 22.97 | 12.99 | 25.97 | 59.95 | 110 |
| Other Liabilities | 96.54 | 130 | 134 | 150 | 182 | 214 |
| Total Liabilities | 516 | 791 | 920 | 1,000 | 1,140 | 1,334 |
| Fixed Assets | 124 | 174 | 248 | 279 | 327 | 388 |
| CWIP | 11.95 | 43.82 | 26.91 | 57.78 | 57.76 | 67.76 |
| Investments | 9.03 | 17.07 | 12.04 | 12.04 | 15.06 | 19.07 |
| Other Assets | 372 | 556 | 632 | 650 | 740 | 859 |
| Inventories | 69.75 | 140 | 224 | 207 | 242 | 286 |
| Trade receivables | 214 | 248 | 262 | 238 | 344 | 360 |
| Cash & equivalents | 43.88 | 107 | 60.83 | 113 | 101 | 117 |
| Total Assets | 516 | 791 | 920 | 1,000 | 1,140 | 1,334 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Cash from operating activity | 82.73 | 75.69 | 44.83 | 115 | 2.99 | 61.76 |
| Cash from investing activity | −82.70 | −133 | −23.93 | −120 | −19.94 | −82.73 |
| Cash from financing activity | −3.99 | 70.89 | −24.97 | 2.99 | 18.98 | −75.88 |
| Net cash flow | −3.99 | 13.97 | −3.99 | −1.99 | 1.99 | −96.79 |
| Capex | 41.88 | 81.81 | 75.72 | 76.82 | 63.80 | 90.79 |
| Free cash flow | 40.83 | −5.97 | −29.89 | 37.85 | −60.77 | −29.88 |
| CFO / OP % | 70.0% | 61.0% | 47.0% | 157.0% | 22.0% | 59.0% |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Debtor days | 120 | 126 | 108 | 128 | 152 | 124 |
| Inventory days | 88 | 163 | 175 | 202 | 205 | 191 |
| Days payable | 93 | 111 | 81 | 93 | 100 | 93 |
| Cash conversion cycle | 116 | 179 | 203 | 238 | 257 | 224 |
| Working capital days | 120 | 158 | 164 | 185 | 179 | 161 |
| ROCE % | — | 40.0% | 27.0% | 11.0% | 13.0% | 17.0% |
For the Jun 2026 quarter, India Pesticides reported sales of ₹253 Cr, down 8.4% year on year and net profit of ₹23.06 Cr, down 34.2% year on year. The operating margin was 14.0%.
India Pesticides' sales for the year to Mar 2026 were ₹1,060 Cr; over the last twelve months they were ₹1,036 Cr.
Net profit for the year to Mar 2026 was ₹120 Cr, and ₹109 Cr over the last twelve months. Earnings per share over the same trailing period were ₹9.38.
India Pesticides reported borrowings of ₹110 Cr at Mar 2026, against cash and equivalents of ₹117 Cr.
Cash from operations was ₹61.76 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹29.88 Cr.